Silexion Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLXN and other ETFs, options, and stocks.

About SLXN

Silexion Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery and development of treatments for KRAS-driven cancers. The company was founded on November 30, 2008 and is headquartered in in Modiin, Israel. 

CEO
Ilan Hadar
CEOIlan Hadar
Employees
14
Employees14
Headquarters
Ramat-Gan, Tel Aviv
HeadquartersRamat-Gan, Tel Aviv
Founded
2008
Founded2008
Employees
14
Employees14

SLXN Key Statistics

Market cap
2.76M
Market cap2.76M
Price-Earnings ratio
-0.03
Price-Earnings ratio-0.03
Dividend yield
Dividend yield
Average volume
83.15K
Average volume83.15K
High today
$2.74
High today$2.74
Low today
$2.59
Low today$2.59
Open price
$2.59
Open price$2.59
Volume
31.06K
Volume31.06K
52 Week high
$223.60
52 Week high$223.60
52 Week low
$2.31
52 Week low$2.31

Stock Snapshot

As of today, Silexion Therapeutics(SLXN) shares are valued at $2.69. The company's market cap stands at 2.76M, with a P/E ratio of -0.03.

During the trading session on 2026-07-05, Silexion Therapeutics(SLXN) shares reached a daily high of $2.74 and a low of $2.59. At a current price of $2.69, the stock is +3.9% higher than the low and still -1.7% under the high.

Trading volume for Silexion Therapeutics(SLXN) stock has reached 31.06K, versus its average volume of 83.15K.

Over the past 52 weeks, Silexion Therapeutics(SLXN) stock has traded between a high of $223.60 and a low of $2.31.

Over the past 52 weeks, Silexion Therapeutics(SLXN) stock has traded between a high of $223.60 and a low of $2.31.

People also own

Based on the portfolios of people who own SLXN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.